Investor Relations

Advanced therapies for the sports medicine and severe burn care markets

Investor Relations

Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Stephen G. Sudovar Elected Chairman of Aastrom Biosciences' Board of Directors
Stephen G. Sudovar Elected Chairman of Aastrom Biosciences' Board of Directors Ann Arbor, Michigan, November 16, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM), a clinical development stage company focused on the use of autologous cells for regenerative medicine, announced today that Stephen G.
View HTML
Toggle Summary Aastrom Biosciences, Inc. Reports First Quarter Fiscal Year 2007 Financial Results
Company Reports Clinical Progress and Strengthened Management Team
View HTML
Toggle Summary Webcast Alert: Aastrom Biosciences Announces Its First Quarter Investor Conference Call
Webcast Alert: Aastrom Biosciences Announces Its First Quarter Investor Conference Call Ann Arbor, MI, November 3, 2006 -- Aastrom Biosciences, Inc. (NASDAQ: ASTM) announces the following Webcast: What: Aastrom Biosciences, Inc. First Quarter Fiscal Year 2007 Investor Conference Call When:
View HTML
Toggle Summary Aastrom Biosciences to Present at Rodman & Renshaw
Aastrom Biosciences to Present at Rodman & Renshaw Ann Arbor, Michigan, November 2, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that George W. Dunbar, President and Chief Executive Officer, and Elmar R. Burchardt, MD, PhD, Vice President, Medical Affairs, will present at the
View HTML
Toggle Summary Webcast Alert: Aastrom Biosciences Announces Webcast of Its Annual Meeting of Shareholders
Webcast Alert: Aastrom Biosciences Announces Webcast of Its Annual Meeting of Shareholders Ann Arbor, MI, October 27, 2006 -- Aastrom Biosciences (NASDAQ: ASTM) announces the following Webcast: What: Aastrom Biosciences Fiscal Year 2006 Annual Meeting of Shareholders When: Thursday, November 2,
View HTML
Toggle Summary Ronnda L. Bartel, Ph.D. Joins Aastrom Biosciences As Vice President Research & Development
Ronnda L. Bartel, Ph.D. Joins Aastrom Biosciences As Vice President Research & Development Ann Arbor, Michigan, October 16, 2006 – Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that Ronnda L. Bartel, Ph.D. has joined the Company as Vice President of Research and Development. Dr.
View HTML
Toggle Summary Aastrom Biosciences to Present at BIO Investor Forum
Aastrom Biosciences to Present at BIO Investor Forum Ann Arbor, Michigan, October 12, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that George W. Dunbar, President and Chief Executive Officer, will be presenting at the 2006 BIO Investor Forum.
View HTML
Toggle Summary Aastrom Biosciences' CFO to Present at Noble Financial Group Small Cap Conference
Aastrom Biosciences' CFO to Present at Noble Financial Group Small Cap Conference Ann Arbor, Michigan, September 21, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that Gerald D. Brennan, Jr., Vice President Administrative & Financial Operations and Chief Financial Officer, will
View HTML
Toggle Summary Aastrom Biosciences Reports Interim Data From Long Bone Non-Union Fracture Clinical Trial
Promising Results Demonstrated in Patients
View HTML
Toggle Summary Aastrom Biosciences to Present at Merriman Curhan Ford & Co. 3rd Annual Investor Summit
Aastrom Biosciences to Present at Merriman Curhan Ford & Co. 3rd Annual Investor Summit Ann Arbor, Michigan, September 14, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that George W. Dunbar, President and Chief Executive Officer, Gerald D.
View HTML

Day High:
Day Low:
Volume:
on
Data Provided by Refinitiv. Minimum 15 minutes delayed.